Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.
For more information on how to use this blog click here, the HCV drug pipeline click here, and for more information on HCV clinical trials click here
Wednesday, March 30, 2011
Entecavir and Truvada an option for HBV for treatment-experienced HIV/HBV-co-infected patients
“Our study shows that this combination in co-infected patients appears safe and has efficacy, with reductions in HBV [hepatitis B virus] DNA and nearly 40% achieving an undetectable viral load in just over a year,” comment the investigators, who emphasise that their patients had extensive experience of hepatitis B therapy.